H&T Presspart has acquired novelex AG from Liberta Partners
novelex is an integral partner of the pharmaceutical industry worldwide. The company provides design, development, manufacturing, assembly and packaging services for custom medical and drug delivery solutions. The team consists of 100 employees across engineering, molding, assembly, logistics and quality segments. The company offers its customers safe and high-quality complete plastic solutions in the healthcare sector. novelex also has a reputation for the highest quality “made in Switzerland” and completely integrated service solutions required by the pharmaceutical and laboratory industry. Thereby, the company provides complete product development solutions from scratch. novelex produces over 38 million medical devices annually.
With the addition of novelex, H&T Presspart extends its focus and completely integrated product solution offerings for pharmaceutical clients. Christian Krätzig, President of H&T Presspart, commented, “novelex’s business is an excellent strategic fit. The acquisition will open up new opportunities to accelerate growth. novelex‘s extensive experience in the delivery of high-quality components and devices for pharmaceutical clients complements our offering and capabilities in the growing drug delivery device market.”
Lincoln International acted as exclusive mergers and acquisitions advisor for H&T Presspart, working closely with the shareholders and management throughout the process. This included providing strategic and tactical advisory expertise at critical moments during the due diligence and final phase of the process. The transaction adds to Lincoln International’s successful track record in the global healthcare space and demonstrates once more the firm’s proven buy-side expertise. Financial terms of the transaction were not disclosed.
About H&T Presspart
H&T Presspart is a market-leading manufacturer of drug delivery devices and components focusing on respiratory treatments, with over 50 years of experience. The company enjoys a worldwide reputation for competence, quality and innovation in the pharmaceutical market. H&T Presspart’s new product development center and inhalation product technology center support its customers’ new product developments and strategic initiatives. H&T Presspart has three European manufacturing sites and sales offices in China, India, the United States and Uruguay.
About Heitkamp & Thumann Group
Heitkamp & Thumann Group is a leading global partner for the supply of world-class precision-formed components in both metal and plastic. The family-owned group comprises of 14 medium-sized companies located in eight different countries. Efficiency, quality and innovation have always been at the very center of its corporate philosophy and entrepreneurial activities. Highly qualified and motivated employees and lean structures makes Heitkamp & Thumann successful all over the world.
Meet our Senior Team
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt
View More Transactions in Healthcare
Lincoln International advised Veritas Capital on the acquisition of Coronis Health and MiraMed Global Services
Lincoln International advised Perwyn on the acquisition of European Sperm Bank from Axcel
Lincoln International advised Quartz Healthcare, a portfolio company of InfraVia, on the acquisition of radprax from its private shareholders
Lincoln International advised ArchiMed and management on the sale of EUROLyser to Antech Diagnostics, a subsidiary of Mars Veterinary Health
Lincoln International advised G Square on its merge and refinancing of Accomplish and Keys Group into a continuation vehicle
Lincoln International advised Pharos Capital Group on the sale of TechLab to SSI Diagnostica, a portfolio company of Adelis Equity Partners
Lincoln International advised Lab Logistics, a portfolio company of Atlantic Street Capital, on receiving a minority investment from Linden Capital Partners
Lincoln International advised Hartenberg Holding on the sale of a minority stake in FutureLife to CVC
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.